ReviewFrontiers in psychiatry2021
Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary.
Review in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Precipitants and clinical features of serotonin syndrome: a systematic review with patient-level analysis of published case reports and series.European journal of clinical pharmacology · 2026Pooled it
- The role of board-certified psychiatric pharmacists in United States foster care: Opportunities to optimize psychotropic medication use.The mental health clinician · 2026Article
- Clinical determinants of psychiatric care in genetic neurodevelopmental disorders: a cross-sectional analysis.Journal of neurodevelopmental disorders · 2025Article
- Assessing the safety and efficacy of prescribing psychologists in New Mexico and Louisiana.The American psychologist · 2025Article
- Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana.PLOS mental health · 2025Article
- Mental Health Polypharmacy in "Non-Coded" Primary Care Patients: The Effect of Deprescribing.Journal of clinical medicine · 2024Article
- Psychotropic Polypharmacy Among Youths Enrolled in Medicaid.JAMA network open · 2024Article
- Findings from an expert focus group on psychotropic medication deprescribing practices for children and youth with complex needs.Frontiers in child and adolescent psychiatry · 2024Article
- Interactions Between Antidepressants and Intestinal Microbiota.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023Article
- Why psychiatry needs an honest dose of gentle medicine.Frontiers in psychiatry · 2023Review
- Eight Months of Telehealth for a State-Funded Project in Foster Care and Related Services: Progress Made and Lessons Learned.Behavior analysis in practice · 2022Review
- Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey.Journal of child and adolescent psychopharmacology · 2022Article
- Polypharmacotherapy in Psychiatry: Global Insights from a Rapid Online Survey of Psychiatrists.Journal of clinical medicine · 2022Article
- Predictors and Correlates of Psychiatric Polypharmacy Among Child and Adolescent Psychiatric Inpatients: A Retrospective Study.Journal of clinical psychopharmacologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.